RARA and acute promyelocytic leukemia: To elucidate the possible treatment for TBLR1-RARα positive APL and identify several clues for future clinical strategy, the biological response of TBLR1-RARα positive APL cells to ATO treatment and the mechanism involved was investigated in the present study.